Humanwell Healthcare Group Co

Humanwell Healthcare Group Co EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Humanwell Healthcare Group Co (600079.SS) as of Nov 2, 2026 is 13.24. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 15.88 — a change of -16.66% (lower).

EV/OCF

13.24

YoY

-16.66%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Humanwell Healthcare Group Co is 2025 13.24 . EV/OCF (Enterprise Value to Operating Cash Flow) of Humanwell Healthcare Group Co was 2024 15.88 . It decreases by -16.66% lower compared to the previous year.

The Humanwell Healthcare Group Co EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
63.70 CNY
Jan 1, 2019
19.01 CNY
Jan 1, 2020
19.18 CNY
Jan 1, 2021
17.34 CNY
Jan 1, 2022
14.35 CNY
Jan 1, 2023
18.21 CNY
Jan 1, 2024
15.88 CNY
Jan 1, 2025
13.24 CNY
The Humanwell Healthcare Group Co EV/OCF history
YEAREV/OCFYoY
13.24-16.66%
15.88-12.76%
18.21+26.85%
14.35-17.22%
17.34-9.58%
19.18+0.88%
19.01-70.16%
63.70-93.39%
963.67+1,325.86%
67.59-34.85%
103.74+56.34%
66.35—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Humanwell Healthcare Group Co is 13.24 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Humanwell Healthcare Group Co changed from 15.88 to 13.24, representing a -16.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Humanwell Healthcare Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Humanwell Healthcare Group Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Humanwell Healthcare Group Co